Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Friday, December 16, 2016

Rates and determinants of 5-year outcomes after atrial fibrillation–related stroke

Notice that they are doing NOTHING on rehabilitation efforts. If you don't measure rehabilitation failures they will NEVER be worked on and improved. It is up to YOU to change that lack of focus.
https://www.mdlinx.com/internal-medicine/medical-news-article/2015/12/14/atrial-fibrillation-nursing-homes-rehabilitation-stroke/6428881/?
Stroke, 12/14/2015
Accurate population–wide outcome data are essential to inform health service planning to improve atrial fibrillation (AF)–related stroke (AF–stroke) prevention, and provision of rehabilitation, nursing home, and community supports for AF–stroke survivors. AF–stroke is associated with considerable long–term morbidity, fatality, stroke recurrence, and nursing home requirement. Adequately resourced national AF strategies to improve AF detection and prevention are needed. (Not rehab)

Methods

  • The authors investigated rates and determinants of 5-year fatality, stroke recurrence, functional outcomes, and prescribing of secondary prevention medications in AF-stroke in the North Dublin Population Stroke Study.
  • Ascertainment included hot and cold pursuit using multiple overlapping sources.
  • Survival analysis was performed using lifetables and Kaplan-Meier survival curves, and Cox proportional hazard modeling was performed to identify predictors of death and recurrent stroke.

Results

  • Five hundred sixty-eight patients with new stroke were identified, including 177 (31.2%) AF-stroke.
  • At 5 years, 39.2% (confidence interval, 31.5-46.8) of ischemic AF-stroke patients were alive.
  • Congestive heart failure, hypertension, age <65, 65-74 years, and ≥75 years, diabetes mellitus, prior stroke, transient ischemic attack or thromboembolism, vascular disease and female sex (CHA2DS2-VASc) score (hazard ratio [HR], 1.34; P<0.001), CHADS2 score (HR 1.42, P=0.004), National Institute of Health Stroke Scale (HR, 1.09; P<0.0001), and subtherapeutic international normalized ratio (<2.0) at stroke onset (HR, 3.29; P=0.003) were independently associated with 5-year fatality, whereas warfarin (HR, 0.40; P=0.001) and statin use after index stroke (HR, 0.52; P=0.005) were associated with improved survival.
  • The 5-year recurrence rate after ischemic AF-stroke was 21.5% (confidence interval, 14.5–31.3).
  • Trends toward greater risk of recurrence were observed for persistent AF (HR, 3.09; P=0.07) and CHA2DS2-VASc score (HR, 1.34; P=0.07).
  • Nursing home care was needed for 25.9% of patients.
Go to PubMed Go to Abstract Print Article Summary Cat 2 CME Report

No comments:

Post a Comment